论文部分内容阅读
目的:探讨子宫内膜间质肉瘤(endometrial stromal sarcoma,ESS)的临床治疗方法。方法:回顾性分析我院收治的37例子宫内膜间质肉瘤的临床资料,并按照国际抗肿瘤协会对子宫肉瘤的分类标准和FIGO对ESS的分期标准和/或放疗。随访5年,比较不同类别及不同期别患者的复发及5年生存率。结果:低度恶性肿瘤和低分期患者的存活率显著高于高度恶性肿瘤和高分期患者(P<0.05),且年龄小于50岁的患者的存活率显著高于年龄大于50岁的患者。结论:子宫内膜间质肉瘤的预后不仅与临床分期及分类相关,而且对术后开展积极的放疗和化疗也具有重要意义。
Objective: To investigate the clinical treatment of endometrial stromal sarcoma (ESS). Methods: A retrospective analysis of 37 cases of endometrial stromal sarcoma admitted to our hospital clinical data, and in accordance with the International Society of Antitumor on the classification of uterine sarcoma and FIGO ESS staging standards and / or radiotherapy. The patients were followed up for 5 years to compare the recurrence rates and 5-year survival rates of different types and stages of patients. Results: The survival rate of patients with low-grade malignancy and low staging was significantly higher than that of patients with highly malignant tumors and high staging (P <0.05). The survival rate of patients younger than 50 years old was significantly higher than that of patients older than 50 years old. Conclusion: The prognosis of endometrial stromal sarcoma is not only related to the clinical stage and classification, but also to the active radiotherapy and chemotherapy after surgery is also of great significance.